gemcitabine has been researched along with Lymphedema in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Straus, DJ | 1 |
Korniyenko, A; Lozada, J; Ranade, A; Sandhu, G | 1 |
Bamberg, M; Brandes, A; Plasswilm, L; Reichmann, U | 1 |
1 review(s) available for gemcitabine and Lymphedema
Article | Year |
---|---|
Chemotherapy only for localized Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachial Plexus; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fibrosis; Gemcitabine; Heart; Hodgkin Disease; Humans; Hypothyroidism; Lung; Lymphedema; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Risk Assessment; Secondary Prevention; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 2011 |
2 other study(ies) available for gemcitabine and Lymphedema
Article | Year |
---|---|
Recurrent lower extremity pseudocellulitis.
Topics: Antimetabolites, Antineoplastic; Cellulitis; Deoxycytidine; Drug Eruptions; Gemcitabine; Humans; Inflammation; Lower Extremity; Lung Neoplasms; Lymphedema; Male; Middle Aged | 2012 |
Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine--a report of three cases.
Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Eruptions; Erysipeloid; Exanthema; Female; Gemcitabine; Humans; Lymphedema; Middle Aged; Neoplasms | 2000 |